Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/1/2000 First Published: 9/1/2000


1.		Phase I Study of Indole-3-carbinol for Prevention of Breast Cancer (Summary Last Modified 11/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Prevention				Completed				18 to 65				NCI				KUMC-6530-95 NCI-P00-0162

Last Modified: 3/27/2003 First Published: 4/1/2002


2.		Phase I Study of Indole-3-Carbinol For the Prevention of Breast Cancer in Non-Smoking Women At High Risk For Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Prevention				Completed				18 to 70				NCI				KUMC-8508-01 NCI-P02-0217, NCT00033345

Last Modified: 5/22/2006 First Published: 12/22/2004


3.		Phase I Randomized Chemoprevention Study of Indole-3-carbinol in Healthy Participants

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Prevention				Completed				18 to 70				NCI				KUMC-HSC-9139-2 NCT00100958, N01-CN-35008-2

Last Modified: 5/5/2008 First Published: 1/31/2008


4.		Randomized Pilot Study of Brassica Vegetables Versus Indole-3-Carbinol in Patients With PSA Recurrence After Prostatectomy for Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Behavioral study, Treatment				Closed				Over 18				NCI				VU-VICC-URO-0369 VICC-URO-0369, VU-VICC-041001, NCT00607932

Select All on One Page